J-Pharma Selected as the “ NEXT UNICORN 2024” by the Nihon Keizai Shimbun (Nikkei)

December 23, 2024
J-Pharma Co., Ltd.

J-Pharma Co., Ltd. (Headquarters: Yokohama, Kanagawa Prefecture, President & CEO: Masuhiro Yoshitake) is pleased to announce that J-Pharma has been selected as one of the “NEXT UNICORNS 2024” announced by the Nihon Keizai Shimbun (Nikkei).

NEXT UNICORNS 2024

A collection on “NEXT Unicorns”, candidates for companies with an enterprise value of $1 billion (approximately 150 billion yen) or more. Of the companies included in the 2024 “NEXT Unicorn Survey”, 132 companies with an estimated enterprise value of 5 billion yen or more were registered. The number of unlisted unicorns with enterprise value of $1 billion or more was five. The estimated enterprise value is as of the end of September 2024. The estimates were made by the Nihon Keizai Shimbun (Nikkei) with the cooperation of the Japan Venture Capital Association and Kepple (Minato, Tokyo), a service for investors.

(Excerpts from Nikkei’s NEXT Unicorn Survey: Searching for the Next Industry Leaders)

List of companies selected as NEXT Unicorns in 2024
https://www.nikkei.com/compass/mokuji/unicorn/unicorn_list.html

[For further information, please contact.]
J-Pharma Co., Ltd.,
Administration Department, Public Relations
TEL: 045-506-1155
FAX: 045-506-1156
Mail: info@j-pharma.com